Last quarter (Q ), Albireo Pharma's total revenue was $9.83M, an increase of 168.34% from the same quarter last year. In Q, Albireo Pharma's net income was $-37.80M. See Albireo Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 57.39M	$ 40.58M	$ 8.31M	$ 9.64M	$ 12.74M	$ 1.00K
Cost of Revenue	$ 2.55M	$ 1.36M	$ 0.00	-	-	-
Gross Profit	$ 54.84M	$ 39.22M	$ 8.31M	-	-	-
Operating Expense	$ 177.76M	$ 162.71M	$ 104.58M	$ 70.75M	$ 50.63M	$ 24.58M
Operating Income	$ -122.91M	$ -123.48M	$ -96.27M	$ -61.11M	$ -37.89M	$ -24.58M
Net Non Operating Interest Income Expense	$ -11.41M	$ -13.93M	$ -11.36M	$ -5.30M	$ -4.84M	$ 40.00K
Other Income Expense	$ -613.00K	$ 103.39M	-	$ 3.69M	$ -3.36M	$ 335.00K
Pretax Income	$ -134.93M	$ -34.03M	$ -107.63M	$ -62.72M	$ -46.09M	$ -24.20M
Tax Provision	$ -3.79M	$ 0.00	-	$ 0.00	$ 20.00K	$ 212.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -131.15M	$ -34.03M	$ -107.63M	$ -62.72M	$ -46.11M	$ -24.41M
Basic EPS	$ -6.72	$ -1.77	$ -6.73	$ -5.04	$ -3.94	$ -3.12
Diluted EPS	$ -6.72	$ -1.77	$ -6.73	$ -5.04	$ -3.94	$ -3.12
Basic Average Shares	$ 77.91M	$ 19.22M	$ 15.98M	$ 12.44M	$ 11.70M	$ 7.82M
Diluted Average Shares	$ 77.91M	$ 19.22M	$ 15.98M	$ 12.44M	$ 11.70M	$ 7.82M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 180.30M	$ 164.06M	$ 104.58M	$ 70.75M	$ 50.63M	$ 24.58M
Net Income From Continuing And Discontinued Operation	$ -131.15M	$ -34.03M	$ -107.63M	$ -62.72M	$ -46.11M	$ -24.41M
Normalized Income	$ -130.53M	$ -34.03M	$ -107.63M	$ -62.72M	$ -46.11M	$ -24.41M
Interest Expense	$ 11.41M	$ 13.93M	$ 11.36M	$ 5.30M	$ 4.84M	-
EBIT	$ -123.53M	$ -20.10M	$ -96.27M	$ -57.42M	$ -41.25M	$ -24.58M
EBITDA	$ -123.10M	$ -19.82M	$ -96.08M	$ -57.29M	$ -41.21M	$ -24.54M

Currency in USD

Albireo Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing